SCHEMBL23960675

SCHEMBL23960675

CCOC(=O)CC1(CN)CCCC(C)C1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.53
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
BLM P54132 1/20 0.36
CACNA2D1 P54289 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KMT2A Q03164 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
GAA P10253 2/20 0.32
MGAM O43451 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
CTDSP1 Q9GZU7 1/20 0.31
CHRM1 P11229 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7450992 0.87 CYP1A2 (0.57) CYP1A2ALDH1A1KDM4ETDP1USP2
Hydrochloric Acid SCHEMBL7450987 0.85 CYP1A2 (0.55) CYP1A2ALDH1A1KDM4ETDP1USP2
SCHEMBL23960622 0.84 CYP1A2 (0.36) CYP1A2ALDH1A1KDM4ETDP1USP2
SCHEMBL23007584 0.81 ALDH1A1 (0.48) CYP1A2ALDH1A1KDM4EUSP2LMNA
SCHEMBL27726 0.80 CYP1A2 (0.81) CYP1A2ALDH1A1USP2LMNATSHR
SCHEMBL3866042 0.80 CYP1A2 (0.81) CYP1A2ALDH1A1USP2LMNATSHR
SCHEMBL2338208 0.80 CYP1A2 (0.81) CYP1A2ALDH1A1USP2LMNATSHR
SCHEMBL6377387 0.80 CYP1A2 (0.81) CYP1A2ALDH1A1USP2LMNATSHR
SCHEMBL7416439 0.80 CYP1A2 (0.81) CYP1A2ALDH1A1USP2LMNATSHR
SCHEMBL466295 0.80 ALDH1A1 (0.56) CYP1A2ALDH1A1KDM4EUSP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021216753-A1 FLUORINATED DERIVATIVES OF GABAPENTIN AND METHODS OF USE THEREOF THE GENERAL HOSPITAL CORPORATION (US) 2021-10-28 WO disclosed